CEO Shahar Ramps Up QTREX Quantum Shares in Bold Buying Spree, Investors Watch for Price Rally

Insider Buying Spree Signals Confidence – but Watch the Bottom Line

Ben‑Noon Dagi Shahar, QTREX Quantum’s CEO, has added 14,093 ordinary shares to his position on October 13, 2026, purchasing the stock at $1.49 through the company’s management share‑purchase plan. The transaction follows a series of large purchases earlier in the year—18,181 shares at $1.67 on October 9 and 168,894 shares at $0.71 on September 28—bringing Shahar’s holdings to a total of 3,664,314 shares. While the most recent buy is modest relative to the June‑to‑September spike, it underscores an ongoing pattern of accumulation that has been consistent across the company’s insider cohort.

What Investors Should Take Away

From a market‑watching perspective, repeated insider purchases can be interpreted as a positive signal: the CEO believes the stock is undervalued or poised for a rebound. However, the context matters. QTREX’s share price has been volatile, dipping below the Nasdaq minimum bid‑price threshold in mid‑October but subsequently stabilising above $1.00 for several days. The company’s P/E ratio remains negative at –5.31, and its market cap hovers just over $100 million, indicating that the stock still sits in a speculative zone. Investors should therefore view Shahar’s buying as a vote of confidence that does not, on its own, guarantee a turnaround. Coupled with the company’s recent Nasdaq notification and ongoing compliance efforts, the insider activity suggests that management is willing to invest in the company’s future but remains cautious of the short‑term price swings.

Shahar’s Insider Profile: Accumulation, Not Divestment

Shahar’s transaction history paints a picture of a CEO who is steadily building a long‑term stake rather than seeking quick liquidity. Since the company’s inception, his purchases have been concentrated in two bursts: a massive 550,000‑share buy in late August at zero cost (likely a grant or incentive under the employee share‑option plan) and a second, smaller buy in early September at $0.00. The June‑September series of purchases—spanning $0.71 to $1.67—reflects a willingness to pay a premium as the stock recovered from a low. Shahar has never sold any shares; his holdings have grown from a few hundred thousand to over 3.6 million shares, indicating a long‑term commitment. This pattern contrasts with other senior executives, some of whom have sold or held smaller positions, suggesting that Shahar is more aggressively aligning his interests with those of shareholders.

Implications for QTREX’s Strategic Horizon

The CEO’s sustained buying activity may bolster investor confidence, especially as the company works to satisfy Nasdaq’s bid‑price requirements and positions itself for a potential surge in its medical‑device business. However, the company’s underlying fundamentals—negative earnings, a high price‑to‑sales ratio (not provided here but implied by the negative P/E) and a history of compliance challenges—mean that insider buying alone is insufficient to drive a long‑term upside. Investors should monitor whether the company can translate its R&D pipeline into revenue, achieve consistent profitability, and maintain a price above $1.00 for a full compliance period. If those milestones are met, Shahar’s accumulation could be a harbinger of a meaningful price rally; if not, the CEO’s buying might simply reflect an optimistic outlook that fails to materialise in the broader market.